The GO Precision Medicine Portfolio™ is a suite of products and services that addresses the full range of requirements for precision medicine in molecular pathology and medical genetics. The Portfolio supports test validation and production, clinical decision support, and analytics for both monitoring and discovery. The organizing philosophy is Streamlining, Simplifying, and Unifying. Today’s products include the GO Validation Toolkit™, the GO Clinical Workbench™, GenomAnalytics™, and Scientific Services to help clients achieve their goals.
Every decision made in the GO Clinical Workbench is name, time and date stamped. All data are exportable for audit purposes and any user decision made that overrides a customer-defined system recommendation requires a comment. In addition, all data remain within the institutions firewall and PHI data are encrypted.
The application is installed within your firewall. No data are ever sent outside your firewall. All PHI data are encrypted, and no PHI data are ever written to disk in plain text. Access to data is password- and role-restricted. The Workbench has been gray-box tested and validated by a third-party data security firm.
A clinical report for a typical tumor panel – starting from raw data, and complete with actionable mutations, regions of “Failed Testing”, FDA, NCCN, ASCO and My Cancer Genome® annotations, and relevant clinical trials can be generated in under 20 minutes.
Integrated clinical decision support is provided by data extracted from My Cancer Genome, NCCN, FDA, and ASCO guidelines. These default resources are easily extensible.
When you design your tests for use in the GO Clinical Workbench, you will establish first-pass classification rules. When running a test, you have the ability to override those initial classifications. GenomOncology has worked with care to offer clients a starting point that many clients find satisfactory for their needs, in particular for off-the-shelf panel assays.
My Cancer Genome is a personalized cancer medicine knowledge resource for physicians, patients, caregivers and researchers developed at Vanderbilt University. This knowledge resource provides up-to-date information on what mutations make cancers grow and related therapeutic implications. You can read more about My Cancer Genome and GenomOncology’s involvement here.
Yes. In fact, the GO Clinical Workbench is able to support integration with multiple test modes (CNV, Gene Fusions, Cytogenetics, IHC, etc) to create a comprehensive summary report. Watch this in action in our video ” Unifying multi-assay testing“.
Yes. The GO Clinical Workbench can be used to analyze data and create reports from any number of genes, including whole Exome.
Yes. The GO Clinical Workbench has inherited disease modes. Some of our clients use our products exclusively outside of cancer. We support panels, exomes, genomes, and family testing.
Our products are highly configurable, from analysis workflow to reporting. GenomOncology will work with you to understand your needs so that your installed GO Clinical Workbench matches your lab’s preferred workflow and captures your approach to each test that you offer. Other areas of customization can include (1) report templates specific to each test and even specific to different physicians, (2) interpretation rules, (3) summary reporting for multiple complementary assays: NGS, FISH, karyotyping, IHC, and arrays.
Absolutely. A first step in working with each client is to understand their workflow so that we can install their tools configured, or even customized, for them.